Akari Therapeutics, Plc
$10.70
+1.69 (+18.76%)
Price as of Aug 28, 2026 market close
Performance
- 1 Month
- +33.7%
- 3 Months
- -34.9%
- YTD
- -7.4%
- 1 Year
- -67.6%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 296.9%
- Largest decline max drawdown, since Aug 2025
- -93.2%
- Risk-adjusted return Sharpe ratio, 1-year
- 0.43
Own AKTX?
See how AKTX contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.